RECURRENT ESOPHAGEAL CARCINOMA
Clinical trials for RECURRENT ESOPHAGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ESOPHAGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT ESOPHAGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to slow advanced esophageal cancer
Disease control OngoingThis study tested if adding an experimental drug called cixutumumab to standard chemotherapy (paclitaxel) could better control cancer that had spread or returned. It involved 94 adults with advanced esophageal or gastroesophageal junction cancer whose initial treatment had stoppe…
Matched conditions: RECURRENT ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
Cancer trial matches drugs to your Tumor's DNA
Disease control OngoingThis large national trial is testing whether choosing cancer drugs based on the specific genetic changes found in a patient's tumor is more effective than standard approaches. It is for adults with advanced solid tumors, lymphoma, or multiple myeloma that have progressed after at…
Matched conditions: RECURRENT ESOPHAGEAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC